EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence

Yuexi Liu, Qiuying Gu iD, Yao Xiao, Xing Wei, Jinlong Wang, Xiaolan Huang, Hua Linghu

Cancer Management and Research · 2024-07 · Volume 16 · 761-769

DOI: 10.2147/cmar.s469132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Management and Research, 2024-07. Verfasst von Yuexi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

interval debulking surgeryoverall survivalprogression-free survivaltumor marker

Autor:innen und Institutionen

  • Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

ORCID-Profile: Qiuying Gu

Zitieren

APA

Liu, Y., Gu, Q., Xiao, Y., Wei, X., Wang, J., Huang, X., & Linghu, H. (2024). Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence. Cancer Management and Research, Volume 16, 761-769. https://doi.org/10.2147/cmar.s469132

Vancouver

Liu Y, Gu Q, Xiao Y, Wei X, Wang J, Huang X, et al. Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence. Cancer Management and Research. 2024;Volume 16:761-769. doi:10.2147/cmar.s469132

BibTeX
@article{Liu2024,
  author = {Liu, Yuexi and Gu, Qiuying and Xiao, Yao and Wei, Xing and Wang, Jinlong and Huang, Xiaolan and Linghu, Hua},
  title = {Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence},
  journal = {Cancer Management and Research},
  year = {2024},
  volume = {Volume 16},
  pages = {761--769},
  doi = {10.2147/cmar.s469132}
}
Kostenlos starten →